Rays Hong Yuan Jiang

Title: Rays Hong Yuan Jiang and Heme Overdrive in Cancer

Introduction

Rays Hong Yuan Jiang is an inventor based in Tampa, Florida, and is associated with the University of South Florida. His patent describes a proposed cancer-treatment approach based on a metabolic process termed “heme overdrive.”

Latest Patents

Jiang’s patent, “Heme overdrive rewires pan-cancer cell metabolism,” presents a method intended to treat cancer by exploiting cancer cells’ dependence on certain heme-pathway enzymes. The patent describes how cancer cells require genes encoding HMBS, UROS, UROD, and CPOX to accumulate heme intermediates such as protoporphyrin IX (PPIX), while normal cells do not share this dependence.

The proposed approach induces the accumulation of porphyrin metabolites, including PPIX, and then uses a ferroptosis-inducing compound to promote cancer-cell death. The patent presents this strategy as a potential therapeutic target across multiple cancer types, with the aim of limiting toxicity to normal cells. Jiang is credited with 1 patent.

Career Highlights

Jiang’s listed affiliation is the University of South Florida. His patent focuses on cancer metabolism and a proposed therapeutic strategy that targets differences between cancer cells and normal cells.

Collaborations

Jiang’s listed coworker is Gregory Allen Hunter. The patent’s subject matter reflects work involving cancer metabolism and potential therapeutic applications.

Conclusion

Rays Hong Yuan Jiang’s patent proposes targeting cancer cells’ reliance on heme intermediates to support a potential treatment strategy designed to affect cancer cells while sparing normal cells.